Plasma bcl-2 and nitric oxide: Possible prognostic role in patients with metastatic breast cancer

Medical Oncology

Volumn 18, Issue 3, 2001, Pages 171-178

  Gaballah, H E ^a   Salam, I Abdel ^a   Wahab, N Abdel ^b   Mansour, O M ^a  

^a CAIRO UNIVERSITY   (Egypt)

^b NATIONAL CANCER INSTITUTE   (Egypt)

Author keywords

Bcl 2; Breast; Nitric oxide; Prognosis

Indexed keywords

ESTROGEN RECEPTOR; NITRIC OXIDE; PROTEIN BCL 2;

ADULT; ADVANCED CANCER; AGE; AGED; ARTICLE; BLOOD LEVEL; BREAST CANCER; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; DIGESTIVE SYSTEM CANCER; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; LYMPH NODE METASTASIS; METASTASIS; PREMENOPAUSE; PRIORITY JOURNAL; PROGNOSIS;

ADULT; AGED; ANTIBODIES, NEOPLASM; BREAST NEOPLASMS; DISEASE-FREE SURVIVAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENES, BCL-2; HUMANS; MIDDLE AGED; NEOPLASM METASTASIS; NITRIC OXIDE; POSTMENOPAUSE; PROGNOSIS; PROTO-ONCOGENE PROTEINS C-BCL-2; TUMOR MARKERS, BIOLOGICAL;

EID: 0035199998     PISSN: 13570560     EISSN: None     Source Type: Journal    
DOI: 10.1385/MO:18:3:171     Document Type: Article

References (37)

1. Roles for p53 in growth arrest and apoptosis: Putting on the brakes after genotoxic stress
2. The proto-oncogene c-myc and apoptosis
3. Bcl-2: An antidote to programmed cell death
4. BCL-2 gene family and the regulation of programmed cell death
5. Bcl-2 with loss of apoptosis allows accumulation of genetic alterations: A pathway to metastatic progression in human breast cancer
6. Prognostic significance of apoptosis regulators in breast cancer
7. Apoptosis and Bcl-2 expression in relation to age, tumor characteristics and prognosis in breast cancer
8. Clinical significance of bcl-2 gene expression in human breast cancer tissues
9. Molecular biology of nitric oxide synthases
10. Role of nitric oxide in growth of solid tumours: A balancing act
11. Endothelial cell nitric oxide synthase in peritumoral microvessels is a favorable prognostic indicator in premenopausal breast cancer patients
12. Nitric oxide synthase activity in human breast cancer
13. Different expression patterns of nitric oxide synthase isozymes in various gynecological cancers
14. Role of nitric oxide in tumour progression: Lessons from human tumours
15. The Bcl-2 oncoprotein functions as a pro-oxidant
16. Superoxide dismutase: The first twenty years (1968-1988)
17. Detection of c-erbB-2 related protein in sera from breast cancer patients. Relationship to ERBB2 gene amplification and c-erbB-2 protein overexpression in tumour
18. Detection of epidermal growth factor receptor in the serum of gastric carcinoma patients
19. c-erbB-2 oncoprotein assay in ovarian carcinoma and its clinical correlation with prognostic factors
20. The detection of increased amounts of the extracellular domain of the epidermal growth factor receptor in serum during carcinogenesis in asbestosis patients
21. Prognostic significance of serum c-erbB-2 protein in breast cancer patients
22. Regulators of apoptosis in human breast cancer
23. Bcl-2 expression on fine-needle aspirates from primary breast carcinoma: Correlation with other biologic factors
24. Bcl-2 immunostaining: A way to finding unresponsive postmenopausal N+ breast cancer patients
25. Correlations of bcl-2 expression with clinicopathological features in breast cancer
26. Loss of Bcl-2 in invasive breast cancer is associated with high rates of cell death, but also with increased proliferative activity
27. Role of nitric oxide in angiogenesis and tumor progression in head and neck cancer
28. Nitric oxide synthase expression and nitric oxide production in human colon carcinoma tissue
29. Significant correlation of nitric oxide synthase activity and p53 gene mutation in stage I lung adenocarcinoma
30. Serum concentrations of vascular endothelial growth factor and nitrite as an estimate of in vivo nitric oxide in patients with gastric cancer
31. Simultaneous expression of nitric oxide synthase and estrogen receptor in human breast cancer cell lines
32. Nitric oxide synthase activity in human renal cell carcinoma
33. Increased level of exhaled nitric oxide and up-regulation of inducible nitric oxide synthase in patients with primary lung cancer
34. Plasma nitrate plus nitrite changes during continuous intravenous infusion interleukin 2
35. Therapy of cancer metastasis by activation of the inducible nitric oxide synthase
36. Role of nitric oxide in tumor progression: Lessons from experimental tumors
37. Chemical biology of nitric oxide: Insights into regulatory, cytotoxic, and cytoprotective mechanisms of nitric oxide